Clinical trials
Phase 1 Liver Cirrhosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 3 |
| Terminated | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Bristol-Myers Squibb | 2 |
| Alentis Therapeutics AG | 1 |
| Eli Lilly and Company | 1 |
| Elizabeth C. Verna | 1 |
| Georgetown University | 1 |
| GlaxoSmithKline | 1 |
| IlDong Pharmaceutical Co Ltd | 1 |
| Jonathan Stine | 1 |
| Madrigal Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Cirrhosis | 26 |
| Fibrosis | 5 |
| Non-alcoholic Fatty Liver Disease | 4 |
| Ascites | 2 |
| Alcoholism | 1 |
| Carcinoma, Hepatocellular | 1 |
| Cholangitis, Sclerosing | 1 |
| End Stage Liver Disease | 1 |
| Fatty Liver | 1 |
| Frailty | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.